Daxor Corporation announced the payment of a dividend along with the appointment of Michael Feldschuh, currently Executive Vice President, as President and Chief Executive Officer on a temporary basis. Dr. Joseph Feldschuh, President and CEO of Daxor, announced that he will take a medical leave of absence effective on December 14, 2015. Michael Feldschuh, currently the Executive Vice President at Daxor, will assume the position of President and Chief Executive Officer on an interim basis, for the duration of Dr. Feldschuh's temporary leave. Michael Feldschuh served as a member of the Board of Directors for one and a half years prior to joining Daxor's executive team in December of 2014 and has over 25 years of experience on Wall Street and in the medical field. Michael served as a Managing Director and Portfolio Manager for Morgan Stanley for six years and a Managing Director of Millennium Partners for eight years in addition to leading his own hedge fund, Aristarc Capital, from 2009 to 2013.

The Board of Directors has unanimously approved an increase in the annual dividend payment for 2015, to $0.04 per share. This dividend will be paid on December 29, 2015, to Daxor shareholders of record on December 22nd.